Bank of New York Mellon’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.6M | Sell |
1,321,996
-140,422
| -10% | -$5.06M | 0.01% | 1025 |
|
|
2025
Q1 | $45.5M | Sell |
1,462,418
-31,549
| -2% | -$982K | 0.01% | 1027 |
|
|
2024
Q4 | $38.1M | Sell |
1,493,967
-20,898
| -1% | -$533K | 0.01% | 1182 |
|
|
2024
Q3 | $42.9M | Sell |
1,514,865
-18,229
| -1% | -$516K | 0.01% | 1132 |
|
|
2024
Q2 | $40.4M | Buy |
1,533,094
+86,248
| +6% | +$2.27M | 0.01% | 1168 |
|
|
2024
Q1 | $43.9M | Sell |
1,446,846
-136,878
| -9% | -$4.16M | 0.01% | 1110 |
|
|
2023
Q4 | $44.5M | Sell |
1,583,724
-55,063
| -3% | -$1.55M | 0.01% | 1116 |
|
|
2023
Q3 | $44.5M | Sell |
1,638,787
-4,668
| -0.3% | -$127K | 0.01% | 1064 |
|
|
2023
Q2 | $50.5M | Sell |
1,643,455
-70,545
| -4% | -$2.17M | 0.01% | 1014 |
|
|
2023
Q1 | $61.8M | Sell |
1,714,000
-58,472
| -3% | -$2.11M | 0.01% | 879 |
|
|
2022
Q4 | $70M | Buy |
1,772,472
+108,775
| +7% | +$4.3M | 0.02% | 781 |
|
|
2022
Q3 | $66.8M | Buy |
1,663,697
+275,394
| +20% | +$11.1M | 0.02% | 774 |
|
|
2022
Q2 | $58.4M | Buy |
1,388,303
+184,671
| +15% | +$7.76M | 0.01% | 889 |
|
|
2022
Q1 | $46.9M | Sell |
1,203,632
-143,383
| -11% | -$5.59M | 0.01% | 1146 |
|
|
2021
Q4 | $53.7M | Sell |
1,347,015
-355,974
| -21% | -$14.2M | 0.01% | 1102 |
|
|
2021
Q3 | $61.5M | Buy |
1,702,989
+709,683
| +71% | +$25.6M | 0.01% | 1002 |
|
|
2021
Q2 | $40.7M | Buy |
993,306
+139,591
| +16% | +$5.72M | 0.01% | 1287 |
|
|
2021
Q1 | $37.2M | Buy |
853,715
+381,025
| +81% | +$16.6M | 0.01% | 1313 |
|
|
2020
Q4 | $23.7M | Buy |
472,690
+216,853
| +85% | +$10.9M | 0.01% | 1546 |
|
|
2020
Q3 | $10.8M | Buy |
255,837
+204,551
| +399% | +$8.61M | ﹤0.01% | 1819 |
|
|
2020
Q2 | $2.49M | Buy |
+51,286
| New | +$2.49M | ﹤0.01% | 2540 |
|